{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:54:59Z","timestamp":1789847699338,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004343","name":"Stavros Niarchos Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.metabol.2020.154307","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T01:15:52Z","timestamp":1593738952000},"page":"154307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A"],"prefix":"10.1016","volume":"110","author":[{"given":"Efstathia","family":"Thymiakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Hornemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Kardassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154307_bb0005","series-title":"High-density lipoproteins: from basic biology to clinical aspects","author":"Fielding","year":"2007"},{"key":"10.1016\/j.metabol.2020.154307_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cpt.1118","article-title":"CETP-inhibition and HDL-cholesterol: a story of CV risk or CV benefit, or both","volume":"104","author":"Nicholls","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.metabol.2020.154307_bb0015","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/ATVBAHA.117.310222","article-title":"High-density lipoprotein function in cardiovascular disease and diabetes mellitus","volume":"38","author":"He","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2020.154307_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10557-018-06846-w","article-title":"High-density lipoprotein function and dysfunction in health and disease","volume":"33","author":"Chiesa","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.metabol.2020.154307_bb0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","article-title":"Non-alcoholic fatty liver disease: the diagnosis and management","volume":"7","author":"Abd El-Kader","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.metabol.2020.154307_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2020.154307_bb0035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2020.154307_bb0040","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1152\/ajpendo.00193.2019","article-title":"HDL flux is higher in patients with nonalcoholic fatty liver disease","volume":"317","author":"McCullough","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154307_bb0045","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1073\/pnas.94.24.13209","article-title":"The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism","volume":"94","author":"Stoffel","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154307_bb0050","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1101\/gad.8.20.2466","article-title":"Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos","volume":"8","author":"Chen","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2020.154307_bb0055","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2020.154307_bb0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/MCB.21.4.1393-1403.2001","article-title":"Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis","volume":"21","author":"Hayhurst","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154307_bb0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1128\/MCB.00927-09","article-title":"Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism","volume":"30","author":"Martinez-Jimenez","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154307_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chroma.2016.02.054","article-title":"Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer","volume":"1440","author":"Narvaez-Rivas","year":"2016","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.metabol.2020.154307_bb0075","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1007\/s00216-014-8255-0","article-title":"LC\/MS lipid profiling from human serum: a new method for global lipid extraction","volume":"406","author":"Pellegrino","year":"2014","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.metabol.2020.154307_bb0080","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.1402870","article-title":"High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function","volume":"194","author":"Tiniakou","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2020.154307_bb0085","first-page":"526","article-title":"Novel mechanism of transcriptional repression of the human ATP binding cassette transporter A1 gene in hepatic cells by the winged helix\/forkhead box transcription factor A2","volume":"2014","author":"Thymiakou","year":"1839","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2020.154307_bb0090","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154307_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12944-017-0429-2","article-title":"HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium","volume":"16","author":"Ruiz","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2020.154307_bb0100","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154307_bb0105","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2174\/0929867321666140303153430","article-title":"Metabolism of HDL and its regulation","volume":"21","author":"Kardassis","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.metabol.2020.154307_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","article-title":"HDL biogenesis, remodeling, and catabolism","volume":"224","author":"Zannis","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.metabol.2020.154307_bb0115","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.HYP.27.4.980","article-title":"Transcriptional regulation of the genes involved in lipoprotein transport. The role of proximal promoters and long-range regulatory elements and factors in apolipoprotein gene regulation","volume":"27","author":"Kardassis","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2020.154307_bb0120","doi-asserted-by":"crossref","first-page":"30719","DOI":"10.1074\/jbc.M110.131771","article-title":"Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors","volume":"285","author":"Mosialou","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154307_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-319-09665-0_8","article-title":"Beyond the genetics of HDL: why is HDL cholesterol inversely related to cardiovascular disease?","volume":"224","author":"Kuivenhoven","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.metabol.2020.154307_bb0130","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/ATVBAHA.113.301634","article-title":"Liver-specific cholesteryl ester hydrolase deficiency attenuates sterol elimination in the feces and increases atherosclerosis in ldlr\u2212\/\u2212 mice","volume":"33","author":"Bie","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2020.154307_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu9010013","article-title":"Hepatic retinyl ester hydrolases and the mobilization of retinyl ester stores","volume":"9","author":"Grumet","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2020.154307_bb0140","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.28472","article-title":"Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2020.154307_bb0145","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep4.1319","article-title":"Relationship between nonalcoholic fatty liver disease susceptibility genes and coronary artery disease","volume":"3","author":"Brouwers","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2020.154307_bb0150","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1073\/pnas.93.25.14788","article-title":"Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility","volume":"93","author":"Weng","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154307_bb0155","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","article-title":"Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis","volume":"11","author":"Wolfrum","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2020.154307_bb0160","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2020.154307_bb0165","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.plipres.2013.09.002","article-title":"Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis","volume":"52","author":"Zerenturk","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.metabol.2020.154307_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.toxlet.2011.11.003","article-title":"Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase","volume":"208","author":"Yoshinari","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.metabol.2020.154307_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13148-016-0304-4","article-title":"Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study","volume":"9","author":"Braun","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.metabol.2020.154307_bb0180","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.3748\/wjg.v22.i29.6742","article-title":"Genetic factors that affect nonalcoholic fatty liver disease: a systematic clinical review","volume":"22","author":"Severson","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154307_bb0185","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.07003","article-title":"Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism","volume":"7","author":"Jetten","year":"2009","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.metabol.2020.154307_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1152\/physiolgenomics.00098.2007","article-title":"Gene expression profiling reveals a regulatory role for ROR alpha and ROR gamma in phase I and phase II metabolism","volume":"31","author":"Kang","year":"2007","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.metabol.2020.154307_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004331","article-title":"Retinoic acid-related orphan receptor gamma (RORgamma): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity","volume":"10","author":"Takeda","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2020.154307_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00213-18","article-title":"Induction of hepatic metabolic functions by a novel variant of hepatocyte nuclear factor 4gamma","volume":"38","author":"Sasaki","year":"2018","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154307_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","article-title":"Targeting nuclear receptors for the treatment of fatty liver disease","volume":"179","author":"Tanaka","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.metabol.2020.154307_bb0210","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154307_bb0215","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.metabol.2020.154307_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.metabol.2020.154307_bb0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","author":"Larter","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2020.154307_bb0230","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1038\/s41598-019-53346-4","article-title":"Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism","volume":"9","author":"Montandon","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154307_bb0235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1515\/znc-2001-3-419","article-title":"Hepatocyte damage induced by carbon tetrachloride: inhibited lipoprotein secretion and changed lipoprotein composition","volume":"56","author":"Boll","year":"2001","journal-title":"Z Naturforsch C J Biosci"},{"key":"10.1016\/j.metabol.2020.154307_bb0240","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI6576","article-title":"Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice","volume":"103","author":"Raabe","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154307_bb0245","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI118269","article-title":"apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes","volume":"96","author":"Huang","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154307_bb0250","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11745-011-3596-3","article-title":"ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5)","volume":"46","author":"Ason","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.metabol.2020.154307_bb0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstrom","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2020.154307_bb0260","first-page":"216","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J Clin Transl Hepatol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520301712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520301712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T09:51:42Z","timestamp":1656064302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520301712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":52,"alternative-id":["S0026049520301712"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154307","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154307"}}